The influence of obesity-related changes in fu on CLATS is similar to its impact on CLGF, causing CLATS to increase with obesity for drug binding to HSA, while it has a decreasing influence on CLATS for drug binding to AAG. The gene discussed is ALB; the disease is obesity disorder.